+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cluster Headache Market by Cluster Headaches Type, Drug Type, Route of Administration, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5968098
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cluster Headache Market grew from USD 381.04 million in 2023 to USD 401.80 million in 2024. It is expected to continue growing at a CAGR of 5.71%, reaching USD 562.38 million by 2030.

Cluster headaches, characterized by severe unilateral head pain and autonomic symptoms, affect individuals uniquely, necessitating effective understanding and treatment strategies. This condition, although rare compared to migraines, significantly impacts patient functionality and quality of life. The necessity for comprehensive market research is underscored by the rising demand for more effective and targeted treatments. Market applications predominantly revolve around pharmaceuticals, medical devices, and alternative therapies, with end-use concentrated in hospitals, specialty clinics, and research organizations.

Key growth factors include increased awareness among healthcare professionals, advancements in neuroimaging that facilitate better diagnosis, and the ongoing development of novel therapeutics. The market also presents potential opportunities with the advent of personalized medicine, telehealth solutions for remote patient management, and new drug formulations in clinical pipelines. Collaboration between pharmaceutical companies and research institutions could expedite innovation and expand treatment options.

However, limitations persist, such as the high cost of novel treatments and limited patient access to specialized care, thereby hindering growth. Additionally, stringent regulatory approvals and inadequate insurance coverage can pose significant challenges. The market is also limited by the complexities involved in understanding the pathophysiology of cluster headaches, which can delay innovative breakthroughs.

Innovation areas ripe for exploration include the development of wearable devices for monitoring headache patterns, further exploration into the genetic basis for individualized therapies, and the integration of AI in predicting headache occurrences. Focusing on these areas could transform the cluster headache landscape by offering more precise and personalized solutions. Overall, the market remains dynamic, shaped by technological advancements and evolving patient needs. Firms aiming to capitalize on this landscape should invest in robust R&D initiatives, foster strategic partnerships, and enhance patient-centric approaches to healthcare delivery, addressing both current limitations and future challenges to drive sustainable business growth.

Understanding Market Dynamics in the Cluster Headache Market

The Cluster Headache Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising prevalence of cluster headaches worldwide
    • Ongoing research and development initiatives in pharmaceuticals and medical technology
    • Surging healthcare investments to advance treatment options
  • Market Restraints
    • Low awareness or misdiagnosis of cluster headaches
  • Market Opportunities
    • Advancements in personalized medicines tailored to individual patient genetics
    • Ongoing product approvals for newly developed cluster headache drugs
  • Market Challenges
    • Complex regulatory requirements for product approvals

Exploring Porter’s Five Forces for the Cluster Headache Market

Porter’s Five Forces framework further strengthens the insights of the Cluster Headache Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Cluster Headache Market

External macro-environmental factors deeply influence the performance of the Cluster Headache Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Cluster Headache Market

The Cluster Headache Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Cluster Headache Market

The Cluster Headache Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Cluster Headache Market

The Cluster Headache Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cluster Headache Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Amgen Inc., AstraZeneca plc, Biogen, Inc., Boehringer Ingelheim International GmbH, electroCore, Inc., Eli Lilly and Company, GlaxoSmithKline PLC, Lundbeck LLC, Lupin Limited, Pfizer Inc., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Cluster Headache Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Cluster Headaches Type
    • Chronic Cluster Headaches
    • Episodic Cluster Headaches
  • Drug Type
    • Anti-Seizure Drugs
    • Calcium Channel Blockers
    • Corticosteroids
    • Ergots
    • Lithium carbonate
    • Melatonin
    • Sumatriptan
  • Route of Administration
    • Intravenous
    • Oral
    • Topical
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of cluster headaches worldwide
5.1.1.2. Ongoing research and development initiatives in pharmaceuticals and medical technology
5.1.1.3. Surging healthcare investments to advance treatment options
5.1.2. Restraints
5.1.2.1. Low awareness or misdiagnosis of cluster headaches
5.1.3. Opportunities
5.1.3.1. Advancements in personalized medicines tailored to individual patient genetics
5.1.3.2. Ongoing product approvals for newly developed cluster headache drugs
5.1.4. Challenges
5.1.4.1. Complex regulatory requirements for product approvals
5.2. Market Segmentation Analysis
5.2.1. Cluster Headaches Type: Increasing need for drugs to treat chronic cluster headache
5.2.2. Distribution Channel: Rising preference for online pharmacies for effective product penetration
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Cluster Headache Market, by Cluster Headaches Type
6.1. Introduction
6.2. Chronic Cluster Headaches
6.3. Episodic Cluster Headaches
7. Cluster Headache Market, by Drug Type
7.1. Introduction
7.2. Anti-Seizure Drugs
7.3. Calcium Channel Blockers
7.4. Corticosteroids
7.5. Ergots
7.6. Lithium carbonate
7.7. Melatonin
7.8. Sumatriptan
8. Cluster Headache Market, by Route of Administration
8.1. Introduction
8.2. Intravenous
8.3. Oral
8.4. Topical
9. Cluster Headache Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Americas Cluster Headache Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cluster Headache Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cluster Headache Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Amgen Expands Therapeutic Portfolio Through Strategic Acquisition of Horizon Therapeutics
13.3.2. Tonix Pharmaceuticals Expands Migraine Treatment Portfolio with Strategic Acquisition
13.3.3. FDA Approval of QULIPTA for Treatment of Chronic and Episodic Migraine
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. CLUSTER HEADACHE MARKET RESEARCH PROCESS
FIGURE 2. CLUSTER HEADACHE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CLUSTER HEADACHE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 13. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS CLUSTER HEADACHE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS CLUSTER HEADACHE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES CLUSTER HEADACHE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES CLUSTER HEADACHE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC CLUSTER HEADACHE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC CLUSTER HEADACHE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CLUSTER HEADACHE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CLUSTER HEADACHE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. CLUSTER HEADACHE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. CLUSTER HEADACHE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CLUSTER HEADACHE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CLUSTER HEADACHE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CLUSTER HEADACHE MARKET DYNAMICS
TABLE 7. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY CHRONIC CLUSTER HEADACHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY EPISODIC CLUSTER HEADACHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY ANTI-SEIZURE DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY ERGOTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY LITHIUM CARBONATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY MELATONIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY SUMATRIPTAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CLUSTER HEADACHE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. CANADA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 40. CANADA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 41. CANADA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 42. CANADA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. MEXICO CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 44. MEXICO CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 45. MEXICO CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 46. MEXICO CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES CLUSTER HEADACHE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC CLUSTER HEADACHE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. CHINA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 62. CHINA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 63. CHINA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. CHINA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. INDIA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 66. INDIA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 67. INDIA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 68. INDIA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. JAPAN CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 74. JAPAN CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 75. JAPAN CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 76. JAPAN CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. THAILAND CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 98. THAILAND CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 99. THAILAND CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 100. THAILAND CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA CLUSTER HEADACHE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 110. DENMARK CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 111. DENMARK CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 112. DENMARK CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 113. DENMARK CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. EGYPT CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 115. EGYPT CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 116. EGYPT CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 117. EGYPT CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. FINLAND CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 119. FINLAND CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 120. FINLAND CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. FINLAND CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. FRANCE CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 123. FRANCE CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 124. FRANCE CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 125. FRANCE CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. GERMANY CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 127. GERMANY CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 128. GERMANY CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 129. GERMANY CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. ITALY CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 135. ITALY CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 136. ITALY CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 137. ITALY CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. NORWAY CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 147. NORWAY CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 148. NORWAY CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 149. NORWAY CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. POLAND CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 151. POLAND CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 152. POLAND CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 153. POLAND CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. QATAR CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 155. QATAR CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 156. QATAR CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 157. QATAR CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. SPAIN CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 171. SPAIN CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 172. SPAIN CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 173. SPAIN CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. TURKEY CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 183. TURKEY CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 184. TURKEY CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 185. TURKEY CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. CLUSTER HEADACHE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 195. CLUSTER HEADACHE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Cluster Headache Market, which are profiled in this report, include:
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca plc
  • Biogen, Inc.
  • Boehringer Ingelheim International GmbH
  • electroCore, Inc.
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Lundbeck LLC
  • Lupin Limited
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...

Table Information